Cargando…
Multimodality Screening For (Peri)Myocarditis In Newly Diagnosed Idiopathic Inflammatory Myopathies: A Cross-Sectional Study
BACKGROUND: Cardiac involvement in idiopathic inflammatory myopathy (IIM or “myositis”) is associated with an approximate 4% mortality, but standardised screening strategies are lacking. OBJECTIVE: We explored a multimodality screening on potentially reversible cardiac involvement –i.e. active (peri...
Autores principales: | Lim, Johan, Walter, Hannah A.W., de Bruin-Bon, Rianne A.C.M., Jarings, Myrthe C., Planken, R. Nils, Kok, Wouter E.M., Raaphorst, Joost, Pinto, Yigal M., Amin, Ahmad S., Boekholdt, S. Matthijs, van der Kooi, Anneke J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041435/ https://www.ncbi.nlm.nih.gov/pubmed/36683515 http://dx.doi.org/10.3233/JND-221582 |
Ejemplares similares
-
Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review
por: Kamperman, Renske G., et al.
Publicado: (2022) -
Assessment of disability in idiopathic inflammatory myopathy: a call for linearity
por: Min, Minoesch, et al.
Publicado: (2021) -
Diagnostic value of additional histopathological fascia examination in idiopathic inflammatory myopathies
por: Lim, J., et al.
Publicado: (2019) -
OptimisAtion of Diagnostic Accuracy in idioPathic inflammaTory myopathies (ADAPT study): a protocol for a prospective diagnostic accuracy study of multimodality testing in patients suspected of a treatable idiopathic inflammatory myopathy
por: Walter, Hannah A W, et al.
Publicado: (2021) -
Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study
por: Lim, Johan, et al.
Publicado: (2020)